Jaspreet Grewal

Jaspreet Grewal is a globally recognized clinician, researcher, and investor with nearly two decades of experience spanning health care, clinical research, regulatory affairs, and strategic advisory across the health and life sciences sector. 

Jaspreet is Chief Executive Officer and Founder of AxialBridge Inc., a global life sciences advisory firm supporting stakeholders across the biotech and life sciences value chain. She is also a Partner at Cerulean Health, a New York-based private equity fund, and the Managing Partner at Access Innovation BioBridge Inc., a Canadian-based, multijurisdictional venture studio supporting growth-stage life science companies. Jaspreet serves as a Board Director of the Canada-U.K. Chamber of Commerce and as a Board Director and Co-Chair of BioAlberta. She also advises multiple public and private organizations in Canada, the U.S., and the U.K. 

Jaspreet completed her medical training at Georgetown University's School of Medicine, with subspecialty training at Yale University. She holds an Executive Certificate in Public Health from the Harvard T.H. Chan School of Public Health and an Executive MBA from the London School of Economics and Political Science.

A published researcher, Jaspreet is deeply engaged in advancing innovation across health care with a particular interest in dual-use technologies, where advances in life sciences and health care intersect with broader strategic, security, and economic applications. She is a dynamic and internationally recognized leader who merges clinical expertise, financial acumen, and a passion for innovation into a career defined by cross-sector impact.